MEDVERITA Artichoke Cynarin Extract 5% 120 caps

Why MEDVERITA Artichoke Extract 5% with Cynarin 120 caps?

• Artichoke leaf extract standardized to contain 5% cynarin,
• supports digestive processes,
• relieves diarrhea, constipation, flatulence and nausea,
• regenerates the liver,
• prevents atherosclerosis,
• can lower cholesterol and glucose levels in the blood.

MEDVERITA Artichoke Extract 5% with Cynarin 120 caps description

Dietary supplement from the MEDVERITA brand, which contains artichoke leaf extract standardized to contain 5% cynarin. It affects the proper functioning of the digestive system and facilitates digestion, eliminating such digestive problems as: nausea, flatulence and a feeling of fullness. Regulates the rhythm of bowel movements and relieves constipation and diarrhea, supporting the probiotic effect. Artichoke stimulates the secretion of bile, showing a choleretic effect, and in addition supports the functioning of the liver and its detoxification. The high content of cynarin makes the product accelerate the cleansing of the body, removes excess toxins and supports detoxification. Artichoke also has positive benefits for the circulatory and heart system, because it counteracts too high levels of ''bad'' cholesterol and triglycerides, thus reducing the risk of developing atherosclerotic changes.

For whom is MEDVERITA Artichoke Extract 5% from Cynarin 120 caps?

Artichoke extract is especially recommended for people struggling with digestive problems and those who care about their figure.

Ingredients: artichoke leaf extract (Cynara scolymus) standardized to 5% cynarin, gelatin (capsule shell). ,/p>

Package: 120 capsules

Portion: 2 capsules

Number of servings per package: 60

Directions for use

Take 2 capsules daily, preferably with a meal.

Contraindications

Not recommended for use by pregnant women, breastfeeding mothers or people who are allergic to any of the ingredients of the product. Do not exceed the recommended daily dose.

Storage

Store in a dark and dry place out of reach of small children.

Responsible entity: Medverita Group, NIP: 676-236-17-16, "ul. Smolki 5/LU5 30-513 Kraków"